These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23856047)

  • 1. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
    Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication.
    Zhu R; Wang M; Xia Y; Qu F; Neyts J; Peng L
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3321-7. PubMed ID: 18445526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.
    Çıkla-Süzgün P; Kaushik-Basu N; Basu A; Arora P; Talele TT; Durmaz I; Çetin-Atalay R; Küçükgüzel ŞG
    J Enzyme Inhib Med Chem; 2015; 30(5):778-85. PubMed ID: 25676325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure based medicinal chemistry approach to develop 4-methyl-7-deazaadenine carbocyclic nucleosides as anti-HCV agent.
    Thiyagarajan A; Salim MT; Balaraju T; Bal C; Baba M; Sharon A
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7742-7. PubMed ID: 23122860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of low molecular weight compounds with complement inhibition activity.
    Master HE; Khan SI; Poojari KA
    Bioorg Med Chem; 2005 Aug; 13(16):4891-9. PubMed ID: 15978815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.
    Wittine K; Stipković Babić M; Makuc D; Plavec J; Kraljević Pavelić S; Sedić M; Pavelić K; Leyssen P; Neyts J; Balzarini J; Mintas M
    Bioorg Med Chem; 2012 Jun; 20(11):3675-85. PubMed ID: 22555152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-aryltriazole acyclonucleosides: synthesis and biological evaluation against hepatitis C virus.
    Liu Y; Xia Y; Li W; Cong M; Maggiani A; Leyssen P; Qu F; Neyts J; Peng L
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3610-3. PubMed ID: 20483607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation.
    Zhang H; Zheng X; Li J; Liu Q; Huang XX; Ding H; Suzuki R; Muramatsu M; Song SJ
    Eur J Med Chem; 2021 Jun; 218():113395. PubMed ID: 33838584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of some benzimidazole derivatives endowed with 1,2,3-triazole as potential inhibitors of hepatitis C virus.
    Youssif BG; Mohamed YA; Salim MT; Inagaki F; Mukai C; Abdu-Allah HH
    Acta Pharm; 2016 Jun; 66(2):219-31. PubMed ID: 27279065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses.
    Peng HK; Chen WC; Lee JC; Yang SY; Tzeng CC; Lin YT; Yang SC
    Org Biomol Chem; 2013 Mar; 11(11):1858-66. PubMed ID: 23377187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative route to the arylvinyltriazole nucleosides.
    Chudinov MV; Prutkov AN; Matveev AV; Grebenkina LE; Konstantinova ID; Berezovskaya YV
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3223-3225. PubMed ID: 27262598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action.
    Windisch MP; Jo S; Kim HY; Kim SH; Kim K; Kong S; Jeong H; Ahn S; No Z; Hwang JY
    Eur J Med Chem; 2014 May; 78():35-42. PubMed ID: 24675178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
    Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
    J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
    Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease.
    Sheng XC; Appleby T; Butler T; Cai R; Chen X; Cho A; Clarke MO; Cottell J; Delaney WE; Doerffler E; Link J; Ji M; Pakdaman R; Pyun HJ; Wu Q; Xu J; Kim CU
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2629-34. PubMed ID: 22366653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
    Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
    J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral evaluation of novel 5-(N-Aryl-aminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazoles and pyrazolyl derivatives.
    Abdel-Aal MT; El-Sayed WA; El-Kosy SM; El-Ashry el SH
    Arch Pharm (Weinheim); 2008 May; 341(5):307-13. PubMed ID: 18404774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus.
    Chen YL; Zacharias J; Vince R; Geraghty RJ; Wang Z
    Bioorg Med Chem; 2012 Aug; 20(15):4790-800. PubMed ID: 22748708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in-vitro anti-hepatitis B virus activity of ethyl 6-bromo-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylates.
    Chen D; Liu Y; Zhang S; Guo D; Liu C; Li S; Gong P
    Arch Pharm (Weinheim); 2011 Mar; 344(3):158-64. PubMed ID: 21384414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication.
    Ban S; Ueda Y; Ohashi M; Matsuno K; Ikeda M; Kato N; Miyachi H
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4774-8. PubMed ID: 23891183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.